Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Dysphagia
ADR ID BADD_A01371
ADR Hierarchy
07      Gastrointestinal disorders
07.01      Gastrointestinal signs and symptoms
07.01.06      Gastrointestinal signs and symptoms NEC
07.01.06.003      Dysphagia
Description A disorder characterized by difficulty in swallowing. [CTCAE] Difficulty in SWALLOWING which may result from neuromuscular disorder or mechanical obstruction. Dysphagia is classified into two distinct types: oropharyngeal dysphagia due to malfunction of the PHARYNX and UPPER ESOPHAGEAL SPHINCTER; and esophageal dysphagia due to malfunction of the ESOPHAGUS. [MeSH]
MedDRA Code 10013950
MeSH ID D003680
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE)
Synonym
Deglutition disorder | Disorder deglutition | Dysphagia | Swallowing difficult | Swallowing disorder | Swallowing impaired | Swallowing spasm | Dysphagia aggravated | Aphagia | Oropharyngeal dysphagia | Esophageal dysphagia | Oesophageal dysphagia | Unable to swallow | Pharyngoesophageal dysphagia | Pharyngo-oesophageal dysphagia | Deglutition Disorders | Deglutition Disorder | Disorders, Deglutition | Swallowing Disorders | Swallowing Disorder | Oropharyngeal Dysphagia | Dysphagia, Oropharyngeal | Esophageal Dysphagia | Dysphagia, Esophageal
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02338Varenicline tartrate--
BADD_D02344Vemurafenib0.012972%
BADD_D02345Venetoclax0.006234%
BADD_D02346Venlafaxine0.000615%
BADD_D02360Vincristine0.000302%
BADD_D02362Vinflunine--
BADD_D02363Vinorelbine--
BADD_D02364Vinorelbine tartrate--
BADD_D02365Vismodegib0.005082%
BADD_D02369Voriconazole--
BADD_D02370Vorinostat0.000437%
BADD_D02378Zalcitabine--
BADD_D02379Zaleplon--
BADD_D02383Zidovudine--
BADD_D02389Ziprasidone hydrochloride--
BADD_D02391Ziprasidone mesylate--
BADD_D02392Zoledronic acid--
BADD_D02393Zolmitriptan0.001354%
BADD_D02394Zolpidem--
BADD_D02395Zolpidem tartrate--
BADD_D02396Zonisamide0.000622%
BADD_D02412Octreotide0.000782%
BADD_D02415Ziprasidone0.003671%
BADD_D02432Glycopyrronium0.023453%
BADD_D02434Cinacalcet0.064226%
BADD_D02436Atorvastatin--
BADD_D02439Levodopa0.003229%
BADD_D02440Lisdexamfetamine0.001711%
BADD_D02441Rasagiline0.007632%
BADD_D02442Magnesium oxide0.000365%
The 19th Page    First    Pre   19 20 21    Next   Last    Total 21 Pages